Twist Bioscience Corporation: Leerink Partners cuts target price to $175 from $190
TWST•Leerink Partners cut its target price for Twist Bioscience Corporation to $175 from $190.
Related News
YETI Holdings: Raymond James cuts target price to $50 from $56
YETI•
Canada's Milestone Pharmaceuticals posts Q3 product revenue after nasal spray launch
MIST•
Ultra Clean Holdings receives Barclays equal-weight rating and $65 target price
UCTT•
Sigma Lithium Q3 2026 net loss more than doubles to USD 25.88 million
SGML•
Digi Power X swings to USD 1 million Q3 net income as revenue rises 85% to USD 12.25 million
DGXX•